CMIC HOLDINGS Co (TSE:2309) ROCE % : 4.14% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CMIC HOLDINGS Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CMIC HOLDINGS Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.14%.

CMIC HOLDINGS Co ROCE % Historical Data

The historical data trend for CMIC HOLDINGS Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CMIC HOLDINGS Co ROCE % Chart

CMIC HOLDINGS Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROCE %

Get a 7-Day Free Trial

6.32

3.53

5.83

18.05

19.84

CMIC HOLDINGS Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															18.66	39.59	13.74	-9.72	4.14

CMIC HOLDINGS Co ROCE % Calculation

CMIC HOLDINGS Co's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2023 )		(A: Sep. 2022 )		(A: Sep. 2023 )
	=	12029	/	( ( (107590 - 35872)	+	(70215 - 20670) )	/ 2 )
	=	12029	/	( (71718	+	49545)	/ 2 )
	=	12029	/	60631.5
	=	19.84 %

CMIC HOLDINGS Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	2032	/	( ( (70215 - 20670)	+	(67874 - 19248) )	/ 2 )
	=	2032	/	( ( 49545	+	48626 )	/ 2 )
	=	2032	/	49085.5
	=	4.14 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

CMIC HOLDINGS Co (TSE:2309) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CMIC HOLDINGS Co ROCE % Related Terms

Thank you for viewing the detailed overview of CMIC HOLDINGS Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CMIC HOLDINGS Co (TSE:2309) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CMIC HOLDINGS Co Ltd (TSE:2309) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo, JPN, 105-0023

Website

https://www.cmicgroup.com

CMIC HOLDINGS Co Ltd is a Japan-based management consulting company. It contributes to the development of the medical and healthcare field. The company is mainly engaged in Contract Research Organization (CRO), Contract Development and Manufacturing (CDMO), Contract Sales Organization (CSO), Innovative Pharma Model (IPM) and healthcare business. CMIC support a wide range of pharmaceutical management services such as data management, statistical analysis, medicine consulting, medical writing, audit, and analytical tests, clinical trials for the medical and pharmaceutical industry, human resource services. It is also engaged in providing sales and marketing support for pharmaceuticals.

CMIC HOLDINGS Co (TSE:2309) Headlines

No Headlines